Bile salt exposure increases proliferation through p38 and ERK MAPK pathways in a non-neoplastic Barrett's cell line

American Journal of Physiology - Gastrointestinal and Liver Physiology

Volumn 290, Issue 2, 2006, Pages

  Jaiswal, Kshama ^a   Lopez Guzman, Christie ^a   Souza, Rhonda F ^b,c   Spechler, Stuart J ^b   Sarosi Jr , George A ^a,d  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^d VA NORTH TEXAS HEALTH CARE SYSTEM   (United States)

Author keywords

Bile salts; Mitogen activated protein kinase

Indexed keywords

ANNEXIN; BILE SALT; BROXURIDINE; GLYCOCHENODEOXYCHOLIC ACID; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; ANTIMETABOLITE; BILE ACID; DIAGNOSTIC AGENT; LIPOCORTIN 5;

ANALYSIS OF VARIANCE; ANIMAL CELL; APOPTOSIS; ARTICLE; BARRETT ESOPHAGUS; BILE REFLUX; CELL COUNT; CELL GROWTH; CELL LINE; CELL PROLIFERATION; CONTROLLED STUDY; COULTER COUNTER; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; HYPOTHESIS; NICK END LABELING; NONHUMAN; PH MEASUREMENT; PRIORITY JOURNAL; SQUAMOUS CELL; STAINING; WESTERN BLOTTING; ADENOCARCINOMA; CYTOLOGY; DRUG EFFECT; ESOPHAGUS; ESOPHAGUS TUMOR; METABOLISM; PHOSPHORYLATION; TUMOR CELL LINE;

ADENOCARCINOMA; ANNEXIN A5; ANTIMETABOLITES; APOPTOSIS; BARRETT ESOPHAGUS; BILE ACIDS AND SALTS; BLOTTING, WESTERN; BROMODEOXYURIDINE; CELL COUNT; CELL LINE; CELL LINE, TUMOR; CELL PROLIFERATION; ESOPHAGEAL NEOPLASMS; ESOPHAGUS; HUMANS; IN SITU NICK-END LABELING; MITOGEN-ACTIVATED PROTEIN KINASES; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION;

EID: 33644850804     PISSN: 01931857     EISSN: 15221547     Source Type: Journal    
DOI: 10.1152/ajpgi.00167.2005     Document Type: Article

References (39)

1. Alpini G, Glaser S, Alvaro D, Ueno Y, Marzioni M, Francis H, Baiocchi L, Stati T, Barbaro B, Phinizy JL, Mauldin J, and LeSage G. Bile acid depletion and repletion regulate cholangiocyte growth and secretion by a phosphatidylinositol 3-kinase-dependent pathway in rats. Gastroenterology 123: 1226-1237, 2002.
2. Brown LM and Devesa SS. Epidemiologic trends in esophageal and gastric cancer in the United States. Surg Oncol Clin N Am 11: 235-256, 2002.
3. Chang LF and Karin M. Mammalian MAP kinase signalling cascades. Nature 410: 37-40, 2001.
4. Fang YW, Han SI, Mitchell C, Gupta S, Studer E, Grant S, Hylemon PB, and Dent P. Bile acids induce mitochondrial ROS, which promote activation of receptor tyrosine kinases and signaling pathways in rat hepatocytes. Hepatology 40: 961-971, 2004.
5. Faubion WA, Guicciardi ME, Miyoshi H, Bronk SF, Roberts PJ, Svingen PA, Kaufmann SH, and Gores GJ. Toxic bile salts induce rodent hepatocyte apoptosis via direct activation of Fas. J Clin Invest 103: 137-145, 1999.
6. Jaiswal K, Tello V, Lopez-Guzman C, Nwariaku F, Anthony T, and Sarosi GA. Bile salt exposure causes phosphatidylinositol-3-kinase-mediated proliferation in a Barrett's adenocarcinoma cell line. Surgery 136: 160-168, 2004.
7. Kaur BS, Ouatu-Lascar R, Omary MB, and Triadafilopoulos G. Bile salts induce or blunt cell proliferation in Barrett's esophagus in an acid-dependent fashion. Am J Physiol Gastrointest Liver Physiol 278: G1000-G1009, 2000.
8. 2 release and hyperproliferation in Barrett's esophagus are COX-2 and PKC-ε dependent. Am J Physiol Gastrointest Liver Physiol 283: G327-G334, 2002.
9. Lagergren J, Bergstrom R, Lindgren A, and Nyren O. Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. N Engl J Med 340: 825-831, 1999.
10. Marucci L, Alpini G, Glaser SS, Alvaro D, Benedetti A, Francis H, Phinizy JL, Marzioni M, Mauldin J, Venter J, Baumann B, Ugili L, and LeSage G. Taurocholate feeding prevents CCl4-induced damage of large cholangiocytes through PI3-kinase-dependent mechanism. Am J Physiol Gastrointest Liver Physiol 284: G290-G301, 2003.
11. Marzioni M, Lesage GD, Glaser S, Patel T, Marienfeld C, Ueno Y, Francis H, Alvaro D, Tadlock L, Benedetti A, Marucci L, Baiocchi L, Phinizy JL, and Alpini G. Taurocholate prevents the loss of intrahepatic bile ducts due to vagotomy in bile duct-ligated rats. Am J Physiol Gastrointest Liver Physiol 284: G837-G852, 2003.
12. Milovic V, Teller IC, Faust D, Caspary WF, and Stein J. Effects of deoxycholate on human colon cancer cells: apoptosis or proliferation. Eur J Clin Invest 32: 29-34, 2002.
13. Moore TC, Jepeal LI, Boylan MO, Singh SK, Boyd N, Beer DG, Chang AJ, and Wolfe M. Gastrin stimulates receptor-mediated proliferatin in human esophageal adenocarcinoma cells. Regul Pept 120: 195-203, 2004.
14. Morales CP, Gandia KG, Ramirez RD, Wright WE, Shay JW, and Spechler SJ. Characterisation of telomerase immortalised normal human oesophageal squamous cells. Gut 52: 327-333, 2003.
15. Morales CP, Ramirez NG, Gandia K, Ramirez RD, Shay JW, and Spechler SJ. Ectopic telomerase for the generation of cell lines from Barrett's esophagus (Abstract). Gastroenterology 122: A57, 2002.
16. Nehra D, Howell P, Williams CP, Pye JK, and Beynon J. Toxic bile acids in gastro-oesophageal reflux disease: influence of gastric acidity. Gut 44: 598-602, 1999.
17. Pai R, Tarnawski AS, and Tran T. Deoxycholic acid activates beta-catenin signaling pathway and increases colon cell cancer growth and invasiveness. Mol Biol Cell 15: 2156-2163, 2004.
18. Pearson G, Robinson F, Beers GT, Xu BE, Karandikar M, Berman K, and Cobb MH. Mitogen-activated protein (MAP) kinase pathways: regulation and physiological functions. Endocr Rev 22: 153-183, 2001.
19. Pohl H and Welch HG. The role of overdiagnosis and reclassification in the marked increase of esophageal adenocarcinoma incidence. J Natl Cancer Inst 97: 142-146, 2005.
20. Qiao L, Studer E, Leach K, McKinstry R, Gupta S, Decker R, Kukreja R, Valerie K, Nagarkatti P, El Deiry W, Molkentin J, Schmidt-Ullrich R, Fisher PB, Grant S, Hylemon PB, and Dent P. Deoxycholic acid (DCA) causes ligand-independent activation of epidermal growth factor receptor (EGFR) and FAS receptor in primary hepatocytes: inhibition of EGFR/mitogen-activated protein kinase-signaling module enhances DCA-induced apoptosis. Mol Biol Cell 12: 2629-2645, 2001.
21. Ramirez RD, Morales CP, Herbert BS, Rohde JM, Passons C, Shay JW, and Wright WE. Putative telomere-independent mechanisms of replicative aging reflect inadequate growth conditions. Genes Dev 15: 398-403, 2001.
22. Reinehr R, Becker S, Wettstein M, and Haussinger D. Involvement of the Src family kinase Yes in bile salt-induced apoptosis. Gastroenterology 127: 1540-1557, 2004.
23. Reinehr R, Graf D, and Haussinger D. Bile salt-induced hepatocyte apoptosis involves epidermal growth factor receptor-dependent CD95-tyrosine phosphorylation in vitro and in vivo (Abstract). Hepatology 38: 241A, 2003.
24. Schoemaker MH, de la Rosa LC, Buist-Homan M, Vrenken TE, Havinga R, Poelstra K, Haisma HJ, Jansen PLM, and Moshage H. Tauroursodeoxycholic acid protects rat hepatocytes from bile acid-induced apoptosis via activation of survival pathways. Hepatology 39: 1563-1573, 2004.
25. Sebolt-Leopold J and Herrera R. Targeting the mitogen-activated protein kinase cascade to treat cancer. Nat Rev Cancer 4: 937-947, 2004.
26. Shirvani VN, Ouatu-Lascar R, Kaur BS, Omary MB, and Triadafilopoulos G. Cyclooxygenase 2 expression in Barrett's esophagus and adenocarcinoma: ex vivo induction by bile salts and acid exposure. Gastroenterology 118: 487-496, 2000.
27. Soldes OS, Kuick RD, Thompson IA, Hughes SJ, Orringer MB, Iannettoni MD, Hanash SM, and Beer DG. Differential expression of Hsp27 in normal oesophagus, Barrett's metaplasia and oesophageal adenocarcinomas. Br J Cancer 79: 595-603, 1999.
28. Souza RF, Shewmake K, Terada LS, and Spechler SJ. Acid exposure activates the mitogen-activated protein kinase pathways in Barrett's esophagus. Gastroenterology 122: 299-307, 2002.
29. Spechler SJ. Barrett's esophagus. N Engl J Med 346: 836-842, 2002.
30. Takikawa Y, Miyoshi H, Rust C, Roberts P, Siegel R, Mandal PK, Millikan RE, and Gores GJ. The bile acid-activated phosphatidylinositol 8-kinase pathway inhibits fas apoptosis upstream of bid in rodent hepatocytes. Gastroenterology 120: 1810-1817, 2001.
31. Toledo A, Yamaguchi J, Wang JY, Bass BL, Turner DJ, and Strauch ED. Taurodeoxycholate stimulates intestinal cell proliferation and protects against apoptotic cell death through activation of NF-kappa B. Dig Dis Sci 49: 1664-1671, 2004.
32. Tselepis C, Morris CD, Wakelin D, Hardy R, Perry I, Luong QT, Harper E, Harrison R, Attwood SEA, and Jankowski JAZ. Upregulation of the oncogene c-myc in Barrett's adenocarcinoma: induction of c-myc by acidified bile acid in vitro. Gut 52: 174-180, 2003.
33. Vaezi MF and Richter JE. Synergism of acid and duodenogastroesophageal reflux in complicated Barrett's esophagus. Surgery 117: 699-704, 1995.
34. Vaezi MF and Richter JE. Role of acid and duodenogastroesophageal reflux in gastroesophageal reflux disease. Gastroenterology 111: 1192-1199, 1996.
35. Wijnhoven BPL, Tilanus HW, and Dinjens WNM. Molecular biology of Barrett's adenocarcinoma. Ann Surg 233: 322-337, 2001.
36. Yamaguchi J, Toledo A, Bass BL, Celeste FA, Rao JN, Wang JY, and Strauch ED. Taurodeoxycholate increases intestinal epithelial cell proliferation through c-myc expression. Surgery 135: 215-221, 2004.
37. Yoon JH, Higuchi H, Werneburg NW, Kaufmann SH, and Gores GJ. Bile acids induce cyclooxygenase-2 expression via the epidermal growth factor receptor in a human cholangiocarcinoma cell line. Gastroenterology 122: 985-993, 2002.
38. Zhang F, Altorki NK, Wu YC, Soslow RA, Subbaramaiah K, and Dannenberg AJ. Duodenal reflux induces cyclooxygenase-2 in the esophageal mucosa of rats: evidence for involvement of bile acids. Gastroenterology 121: 1391-1399, 2001.
39. Zhang F, Subbaramaiah K, Altorki N, and Dannenberg AJ. Dihydroxy bile acids activate the transcription of cyclooxygenase-2. J Biol Chem 273: 2424-2428, 1998.